"AutoNation is proud to join NSU to help drive out cancer through support of this world-class collaborative research institution.”
- Mike Jackson, Chief Executive Officer, AutoNation
Learn about the highly talented scientists who are working diligently to find new methods of prevention and treatment, and eventual cures for various forms of cancer.
Institute Director Associate Professor, Department of Pharmaceutical Sciences, College of Pharmacy
Jean J. Latimer, Ph.D., is director of the NSU AutoNation Institute for Breast Cancer Research and Care and an associate professor and cancer research scientist at NSU’s College of Pharmacy. At NSU, Latimer leads a team that investigates human breast tissue for DNA damage that originates from environmental causes.
Project DirectorProfessor, Public Health, College of Osteopathic Medicine
Stephen Grant, Ph.D. is leading projects that incorporate his research expertise in oncology, developmental biology, DNA repair, and genetics.
Professor Department of Biological Sciences, Halmos College of Natural Sciences and Oceanography
Joe V. Lopez, Ph.D. is does groundbreaking research in genomics, molecular biology, systematics and microbiological research.
Assistant ProfessorDr. Kiran C. Patel College of Osteopathic Medicine
Lubov Nathanson, Ph.D. is an expert in bioinformatics, systems biology, molecular biology and biochemistry.
Professor Research Director, College of Psychology
Jaime Tartar, Ph.D. specializes in behavioral neuroscience, with research expertise in many areas of neuroscience from clinical neurological impairments to basic cell physiology.
Consultant Translational Research and Economic Development
H. Thomas Temple, M.D. has a long-established reputation as a successful surgeon and researcher. His clinical interests are novel treatment of benign and malignant bone and soft tissue tumors in children and adults, tissue transplantation and complex limb reconstruction. His research interests are stem cell applications in bone and cartilage regeneration, tissue banking and developing targeted therapies for sarcomas.